Ayden Scheim


Affiliate Scientist


Please note Dr. Scheim will not be taking any summer students.

Dr. Scheim is an Affiliate Scientist with the Centre on Drug Policy Evaluation, Li Ka Shing Knowledge Institute.

His primary appointment is as an Assistant Professor of Epidemiology in the Drexel University Dornsife School of Public Health in Philadelphia. He is also an Adjunct Assistant Professor in Epidemiology and Biostatistics at Western University. Dr. Scheim investigates the impacts of social, policy, and healthcare environments on the health of populations facing stigma. In particular, his research program involves community-engaged research with transgender populations and structurally vulnerable people who use drugs.

Recent Publications

  1. Scheim, AI, Bauer, GR, Bastos, JL, Poteat, T. Advancing Intersectional Discrimination Measures for Health Disparities Research: Protocol for a Bilingual Mixed Methods Measurement Study. JMIR Res Protoc. 2021;10 (8):e30987. doi: 10.2196/30987. PubMed PMID:34459747 .
  2. Morgan, R, Baker, P, Griffith, DM, Klein, SL, Logie, CH, Mwiine, AA et al.. Beyond a Zero-Sum Game: How Does the Impact of COVID-19 Vary by Gender?. Front Sociol. 2021;6 :650729. doi: 10.3389/fsoc.2021.650729. PubMed PMID:34212026 PubMed Central PMC8239350.
  3. Scheim, AI, Sniderman, R, Wang, R, Bouck, Z, McLean, E, Mason, K et al.. The Ontario Integrated Supervised Injection Services Cohort Study of People Who Inject Drugs in Toronto, Canada (OiSIS-Toronto): Cohort Profile. J Urban Health. 2021;98 (4):538-550. doi: 10.1007/s11524-021-00547-w. PubMed PMID:34181179 PubMed Central PMC8237772.
  4. Chakrapani, V, Scheim, AI, Newman, PA, Shunmugam, M, Rawat, S, Baruah, D et al.. Affirming and negotiating gender in family and social spaces: Stigma, mental health and resilience among transmasculine people in India. Cult Health Sex. 2021; :1-17. doi: 10.1080/13691058.2021.1901991. PubMed PMID:33847243 .
  5. Roth, AM, Mitchell, AK, Mukherjee, R, Scheim, AI, Ward, KM, Lankenau, SE et al.. Prevalence and Correlates of Syringe Disposal Box Use in a Philadelphia Neighborhood with High Levels of Public Drug Injection. Subst Use Misuse. 2021;56 (5):668-673. doi: 10.1080/10826084.2021.1887252. PubMed PMID:33663334 .
  6. Rich, AJ, Scheim, AI, Koehoorn, M, Poteat, T. Non-HIV chronic disease burden among transgender populations globally: A systematic review and narrative synthesis. Prev Med Rep. 2020;20 :101259. doi: 10.1016/j.pmedr.2020.101259. PubMed PMID:33335828 PubMed Central PMC7732872.
  7. Scheim, A, Kacholia, V, Logie, C, Chakrapani, V, Ranade, K, Gupta, S et al.. Health of transgender men in low-income and middle-income countries: a scoping review. BMJ Glob Health. 2020;5 (11):. doi: 10.1136/bmjgh-2020-003471. PubMed PMID:33239337 PubMed Central PMC7689587.
  8. Lacombe-Duncan, A, Kia, H, Logie, CH, Todd, KP, Persad, Y, Leblanc, G et al.. A qualitative exploration of barriers to HIV prevention, treatment and support: Perspectives of transgender women and service providers. Health Soc Care Community. 2021;29 (5):e33-e46. doi: 10.1111/hsc.13234. PubMed PMID:33237600 .
  9. Scheim, AI, Bouck, Z, Tookey, P, Hopkins, S, Sniderman, R, McLean, E et al.. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada. Int J Drug Policy. 2021;87 :102993. doi: 10.1016/j.drugpo.2020.102993. PubMed PMID:33160158 .
  10. Gicquelais, RE, Werb, D, Marks, C, Ziegler, C, Mehta, SH, Genberg, BL et al.. Prevalence and Correlates of Providing and Receiving Assistance With the Transition to Injection Drug Use. Epidemiol Rev. 2020;42 (1):4-18. doi: 10.1093/epirev/mxaa008. PubMed PMID:33024995 PubMed Central PMC7947591.
Search PubMed

Affiliations & Other Activities

Postdoctoral Fellow, University of California San Diego